Efficacy and Safety of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) in Treatment-Naive Adults With HIV-1 and Transmitted Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutations.
Ontology highlight
SUBMITTER: Wong A
PROVIDER: S-EPMC6830961 | biostudies-literature | 2019 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA